Mario Cepeda

760 total citations
19 papers, 628 citations indexed

About

Mario Cepeda is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mario Cepeda has authored 19 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Mario Cepeda's work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (5 papers) and Cell Adhesion Molecules Research (5 papers). Mario Cepeda is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (5 papers) and Cell Adhesion Molecules Research (5 papers). Mario Cepeda collaborates with scholars based in Canada, United States and United Kingdom. Mario Cepeda's co-authors include Henrik S. Olsen, C A Rosen, Sashko Damjanovski, Jian Ni, Reiner Gentz, Kenneth C. Carter, Meena Augustus, Ann L. Cornish, Paul R. Crocker and Sylvie Freeman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Mario Cepeda

19 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Cepeda Canada 10 356 140 135 131 99 19 628
Jizhou Yan China 15 703 2.0× 115 0.8× 83 0.6× 63 0.5× 85 0.9× 31 968
Ying Tong China 19 392 1.1× 146 1.0× 160 1.2× 30 0.2× 216 2.2× 55 945
Robin Ernst United States 8 382 1.1× 67 0.5× 95 0.7× 32 0.2× 73 0.7× 10 647
Fredericus J. van Eeden United Kingdom 9 336 0.9× 206 1.5× 256 1.9× 49 0.4× 30 0.3× 12 706
Pierre‐André Bédard Canada 14 412 1.2× 74 0.5× 134 1.0× 23 0.2× 123 1.2× 29 665
Carrie M. Langdon Canada 14 297 0.8× 79 0.6× 259 1.9× 33 0.3× 366 3.7× 17 717
J.J.M. van Groningen Netherlands 17 456 1.3× 96 0.7× 214 1.6× 13 0.1× 153 1.5× 25 779
Luigi Grassi Italy 14 559 1.6× 237 1.7× 123 0.9× 29 0.2× 74 0.7× 41 859
Svetlana Lebedeva United States 12 879 2.5× 328 2.3× 125 0.9× 25 0.2× 68 0.7× 13 1.0k
Ignacio Palmero Spain 21 713 2.0× 135 1.0× 149 1.1× 42 0.3× 543 5.5× 37 1.2k

Countries citing papers authored by Mario Cepeda

Since Specialization
Citations

This map shows the geographic impact of Mario Cepeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Cepeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Cepeda more than expected).

Fields of papers citing papers by Mario Cepeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Cepeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Cepeda. The network helps show where Mario Cepeda may publish in the future.

Co-authorship network of co-authors of Mario Cepeda

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Cepeda. A scholar is included among the top collaborators of Mario Cepeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Cepeda. Mario Cepeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Williams, Karla C., Mario Cepeda, Ashley V. Makela, et al.. (2019). Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis. Oncogene. 38(19). 3598–3615. 45 indexed citations
3.
Peterson, Timothy E., et al.. (2019). Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma. Frontiers in Oncology. 9. 651–651. 78 indexed citations
4.
Ivanova, Iordanka A., Kevin Barr, Mario Cepeda, et al.. (2019). Targeting FER Kinase Inhibits Melanoma Growth and Metastasis. Cancers. 11(3). 419–419. 14 indexed citations
5.
Cepeda, Mario, Matthew R. Lowerison, Cindy Liu, et al.. (2018). Abstract LB-155: Rapid patient derived xenograft avatars that consider tumor heterogeneity for prediction of cancer immunotherapy responses in metastatic renal cell carcinoma patients. Cancer Research. 78(13_Supplement). LB–155. 1 indexed citations
6.
Cepeda, Mario, et al.. (2017). Stable expression of α1-antitrypsin Portland in MDA-MB-231 cells increased MT1-MMP and MMP-9 levels, but reduced tumour progression.. Journal of Cell Communication and Signaling. 12(2). 479–488. 4 indexed citations
7.
Cepeda, Mario, et al.. (2017). Inhibition of MT1-MMP proteolytic function and ERK1/2 signalling influences cell migration and invasion through changes in MMP-2 and MMP-9 levels. Journal of Cell Communication and Signaling. 11(2). 167–179. 26 indexed citations
8.
Cepeda, Mario, et al.. (2016). The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells. Experimental Cell Research. 350(1). 169–183. 5 indexed citations
9.
Cepeda, Mario, et al.. (2016). Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells. Molecular Cancer. 15(1). 65–65. 29 indexed citations
10.
Nieuwesteeg, Michelle, et al.. (2015). Analysis of Xenopus laevis RECK and Its Relationship to Other Vertebrate RECK Sequences. Journal of Scientific Research and Reports. 6(7). 504–513. 2 indexed citations
12.
Cepeda, Mario, et al.. (2014). Functional Characterization of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) N- and C-Terminal Domains duringXenopus laevisDevelopment. The Scientific World JOURNAL. 2014. 1–10. 5 indexed citations
13.
Cepeda, Mario, et al.. (2013). Knockdown of Pex11β reveals its pivotal role in regulating peroxisomal genes, numbers, and ROS levels in Xenopus laevis A6 cells. In Vitro Cellular & Developmental Biology - Animal. 50(4). 340–349. 7 indexed citations
14.
Walsh, Logan A., Mario Cepeda, & Sashko Damjanovski. (2012). Analysis of the MMP-dependent and independent functions of tissue inhibitor of metalloproteinase-2 on the invasiveness of breast cancer cells. Journal of Cell Communication and Signaling. 6(2). 87–95. 17 indexed citations
15.
Blancato, Jan, et al.. (2001). Human APC2 localization and allelic imbalance.. PubMed. 61(21). 7978–84. 31 indexed citations
16.
Cornish, Ann L., Sylvie Freeman, Jian Ni, et al.. (1998). Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33. Blood. 92(6). 2123–2132. 14 indexed citations
17.
Cornish, Ann L., Sylvie Freeman, Jian Ni, et al.. (1998). Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33. Blood. 92(6). 2123–2132. 152 indexed citations
18.
Olsen, Henrik S., et al.. (1996). Human stanniocalcin: a possible hormonal regulator of mineral metabolism.. Proceedings of the National Academy of Sciences. 93(5). 1792–1796. 186 indexed citations
19.
Vogel, Jonathan, et al.. (1995). THE HIV TAT GENE IS A PROMOTER OF EPIDERMAL SKIN TUMORS. International Journal of Oncology. 7(4). 727–33. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026